| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ICAAC 2002 : Population Pharmacodynamic Assessment of Atazanavir (BMS-232632) Exposure, Genotype, and Safety | published Mon, Nov 10, 2008 - 15:27 EST |
Primary Author: Edward O'Mara, BMS; Primary Cognigen Author: Brenda Cirincione
Primary Author: Edward O'Mara, Bristol-Myers Squibb
Sponsor: Bristol-Myers Squibb
Event: ICAAC 2002
Other Contributors:
D. Randall(1), J. Passarell(2), S. Steinberg(2), E. Ludwig(2), D. Grasela(1), and B. Cirincione(2)
(1) Bristol- Myers Squibb, Princeton, NJ; (2) Cognigen Corp., Buffalo, NY
| Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ICAAC 2002 : Population Pharmacodynamic Assessment of Atazanavir (BMS-232632) Exposure, Genotype, and Safety | published Mon, Nov 10, 2008 - 15:27 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |